Use App
New
Connect your Agent
Trending
News
Earnings
All
DIA
0.10%
SPY
0.44%
QQQ
0.93%
Trending
SMCI
9.57%
SNDK
13.00%
CADL
6.65%
RUM
3.84%
NLST
4.42%
CSCO
8.79%
JD
7.83%
ONDS
7.17%
CBRS
14.22%
PSKY
2.16%
Feed
News
Sentiment
Fundamentals
Info
home
Symbol
GRI
news
Exchange:
NASDAQ
·
Updated 11:44 AM EDT
News
all
press releases
GRI Bio Reports Positive Study Results For Chronic Lung Disease, But Stock Slumps 20% — What Happened?
The company said that the new data indicate that GRI-0621 may support the regeneration of lung tissue.
Stocktwits
Full Article
GRI Bio Drug Shows Promising Lung Function Recovery In Patients With Thickened Lungs
GRI Bio shared promising data from a Phase 2a trial for idiopathic pulmonary fibrosis, a chronic lung disease with no known cause.read more...
Benzinga
Barclays lifts Kojamo, I-RES ratings; cuts Grainger on low yield
investing.com
<
1
>
Advertisement
|
Remove ads.
Home
Watchlist
Trending
News
Explore
Profile